Identification of Therapeutic Targets and Molecular Markers for Glioblastoma Stem Cells.

Kulkarni, Shreya.

2016

Description
  • Abstract: Glioblastoma Multiforme (GBM) is the most common type of malignant brain cancer with a median survival of only 14 months post diagnosis. The current standard of care for all the patients is maximal surgical resection followed by radiation and chemotherapy with temozolomide, a DNA alkylating agent. This treatment reduces the tumor bulk, but is not curative as recurrence is very commo... read more
This object is in collection Genre Permanent URL
ID:
794088700
Component ID:
tufts:20416
To Cite:
DCA Citation Guide    EndNote